ARCHIVES

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

NCI Cooperative Group Clinical Trials Approved

December 25, 2009

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998